Dopamine and cocaine: a transporter is not a receptor

01 / Dopamine functions

Dopamine supports several neural functions.

Dopamine supports movement, motivation, learning and action selection. Reward-related circuits connect outcomes and cues with subsequent behavior. Different pathways and receptors have different roles, making a single “pleasure chemical” account incomplete.^[1]

Cocaine inhibits proteins that clear neurotransmitters from extracellular space. Transporters move molecules across membranes; receptors translate binding into cellular responses. These are distinct targets.

02 / Release and reuptake

Cocaine inhibits neurotransmitter reuptake.

Vesicles release dopamine, which interacts with receptors before transporters help clear it from extracellular space. Cocaine inhibits the dopamine transporter, increasing the availability of released dopamine for signaling within an active neural circuit.^[1]

Cocaine also inhibits norepinephrine and serotonin transporters. Those actions help explain why a dopamine-only account is incomplete. Sympathetic activation, changes in vascular tone and other pharmacological effects contribute to the body’s response. Cocaine also blocks voltage-gated sodium channels, a different molecular target associated with its local anesthetic effects.

Cocaine is not simply a dopamine-receptor agonist. Transporter binding and receptor activation are separate events; the schematic does not assign measured concentrations to either state.

03 / From a synapse to behavior

Transporter effects, learning and behavior

A human PET study by Volkow and colleagues linked dopamine-transporter occupancy with reported cocaine effects in volunteers who regularly used cocaine. It supported a relationship between transporter blockade and the subjective high under those study conditions. It did not provide a safe threshold for use or a complete theory of addiction.^[2]

Repeated drug-associated cues and environments can acquire motivational significance. Craving is not a direct readout of a dopamine deficit, and addiction is not determined by a fixed receptor count. Learning, stress responses, executive control and social circumstances interact over time.

Tolerance and sensitization can affect different responses. Reduced desired effects do not imply proportionately reduced cardiovascular danger. Routes differ in exposure dynamics, but none eliminates cocaine’s major risks.

04 / Beyond the reward circuit

Cardiovascular and neurological risks

Cocaine can disrupt heart rate, blood pressure and electrical activity. Systemic toxicity can include myocardial ischemia, arrhythmias, stroke, seizures and hyperthermia, including after limited prior use. Dopamine-transporter occupancy alone does not describe these cardiovascular and neurological effects.^[3]

Clinical trials support contingency management as an evidence-based behavioral approach for stimulant-use disorder. Recovery varies; transporter pharmacology does not establish a universal receptor-recovery countdown or “dopamine detox” regimen.^[4]